Multiple myeloma is characterized by a highly heterogeneous disease distribution within the bone marrow-containing skeletal system . In this review, we introduce the molecular mechanisms underlying clonal heterogeneity and the spatio-temporal evolution of myeloma. We discuss the clinical impact of clonal heterogeneity, which is thought to be one of the biggest obstacles to overcome therapy resistance and to achieve cure.